1. Home
  2. LQDA vs TIGR Comparison

LQDA vs TIGR Comparison

Compare LQDA & TIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LQDA
  • TIGR
  • Stock Information
  • Founded
  • LQDA 2004
  • TIGR 2014
  • Country
  • LQDA United States
  • TIGR Singapore
  • Employees
  • LQDA N/A
  • TIGR N/A
  • Industry
  • LQDA Biotechnology: Pharmaceutical Preparations
  • TIGR Investment Bankers/Brokers/Service
  • Sector
  • LQDA Health Care
  • TIGR Finance
  • Exchange
  • LQDA Nasdaq
  • TIGR Nasdaq
  • Market Cap
  • LQDA 1.7B
  • TIGR 1.9B
  • IPO Year
  • LQDA 2018
  • TIGR 2019
  • Fundamental
  • Price
  • LQDA $25.95
  • TIGR $10.85
  • Analyst Decision
  • LQDA Strong Buy
  • TIGR Strong Buy
  • Analyst Count
  • LQDA 10
  • TIGR 2
  • Target Price
  • LQDA $31.40
  • TIGR $10.79
  • AVG Volume (30 Days)
  • LQDA 3.4M
  • TIGR 5.2M
  • Earning Date
  • LQDA 08-12-2025
  • TIGR 08-29-2025
  • Dividend Yield
  • LQDA N/A
  • TIGR N/A
  • EPS Growth
  • LQDA N/A
  • TIGR 93.97
  • EPS
  • LQDA N/A
  • TIGR 0.46
  • Revenue
  • LQDA $19,322,000.00
  • TIGR $374,147,409.00
  • Revenue This Year
  • LQDA $190.73
  • TIGR $53.82
  • Revenue Next Year
  • LQDA $421.01
  • TIGR $13.18
  • P/E Ratio
  • LQDA N/A
  • TIGR $22.68
  • Revenue Growth
  • LQDA 30.20
  • TIGR 61.42
  • 52 Week Low
  • LQDA $8.26
  • TIGR $3.39
  • 52 Week High
  • LQDA $26.65
  • TIGR $14.48
  • Technical
  • Relative Strength Index (RSI)
  • LQDA 79.56
  • TIGR 62.36
  • Support Level
  • LQDA $19.02
  • TIGR $10.11
  • Resistance Level
  • LQDA $26.65
  • TIGR $10.90
  • Average True Range (ATR)
  • LQDA 1.53
  • TIGR 0.45
  • MACD
  • LQDA 0.64
  • TIGR 0.04
  • Stochastic Oscillator
  • LQDA 92.88
  • TIGR 89.58

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

About TIGR UP Fintech Holding Ltd representing fifteen

UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.

Share on Social Networks: